RetinalGenix Technologies (RTGN) Profit After Tax (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Profit After Tax of -$590489.0 for Q1 2026, up 5.24% sequentially from -$623127.0 in Q4 2025, and down 0.55% YoY from -$593754.7 in Q1 2025.
RetinalGenix Technologies (RTGN) Profit After Tax (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Profit After Tax for 7 years, with the latest figure at -$590489.0 in Q1 2026.
- Quarterly Profit After Tax fell 0.55% year-over-year to -$590489.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (up 11.96% YoY) and the FY2025 annual result came in at -$2.4 million, up 43.79% from the prior year.
- Profit After Tax improved to -$590489.0 in Q1 2026 per RTGN's latest filing, from -$623127.0 in the prior quarter.
- Over five years, Profit After Tax peaked at -$352143.0 in Q2 2023 and troughed at -$2.5 million in Q3 2022.
- A 5-year average of -$784986.5 and a median of -$623127.0 in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax slumped 354.52% in 2022, then jumped 72.63% in 2025.
- Over 5 years, Profit After Tax stood at -$674946.0 in 2022, then advanced by 19.75% to -$541636.0 in 2023, then tumbled by 60.08% to -$867027.0 in 2024, then increased by 28.13% to -$623127.0 in 2025, then increased by 5.24% to -$590489.0 in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$590489.0, -$623127.0, and -$568791.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -590,489.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -590,489.00 |
| Dec 31, 2025 | -623,127.00 |
| Sep 30, 2025 | -568,791.00 |
| Jun 30, 2025 | -649,418.00 |
| Mar 31, 2025 | -587,259.00 |
| Dec 31, 2024 | -867,027.00 |
| Sep 30, 2024 | -644,291.00 |
| Jun 30, 2024 | -663,633.00 |
| Mar 31, 2024 | -2.15 Mn |
| Dec 31, 2023 | -541,636.00 |
| Sep 30, 2023 | -686,467.00 |
| Jun 30, 2023 | -352,143.00 |
| Mar 31, 2023 | -510,643.00 |
| Dec 31, 2022 | -674,946.00 |
| Sep 30, 2022 | -2.50 Mn |
| Jun 30, 2022 | -359,335.00 |
| Mar 31, 2022 | -375,199.00 |
| Dec 31, 2021 | -409,738.00 |
| Sep 30, 2021 | -551,023.00 |
| Jun 30, 2021 | -534,852.00 |